On the public citation graph

Definition and Classification of Generic Drugs Across the World

https://doi.org/10.1007/s40258-014-0146-1
0 signed · 99 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/9780470571224.pse511openalex-snapshot
Regulatory Strategies and Lessons in the Development of Biosimilars
inferredcites →https://doi.org/10.1016/j.jhealeco.2011.08.006openalex-snapshot
Does price reveal poor-quality drugs? Evidence from 17 countries
inferredcites →https://doi.org/10.1016/s0140-6736(03)13375-2openalex-snapshot
25 years of the WHO essential medicines lists: progress and challenges
inferredcites →https://doi.org/10.1017/cbo9780511618871.009openalex-snapshot
Competition between Generic and Branded Drugs
inferredcites →https://doi.org/10.1111/j.1468-0327.2008.00207.xopenalex-snapshot
Competition in off-patent drug markets: Issues, regulation and evidence
inferredcites →https://doi.org/10.1201/9781420030419openalex-snapshot
Generic Drug Product Development
inferredcites →https://doi.org/10.1201/b15569openalex-snapshot
Generic Drug Product Development
inferredcites →https://doi.org/10.1590/s1020-49892006001000004openalex-snapshot
Definición de medicamento genérico: ¿un fin o un medio? Análisis de la regulación en 14 países de la Región de las Américas
inferredcites →https://doi.org/10.1590/s1020-49892011000200002openalex-snapshot
Publicidad y promoción de medicamentos: regulaciones y grado de acatamiento en cinco países de América Latina
inferredcites →https://doi.org/10.1787/bfc02193-enopenalex-snapshot
World population growth
inferredcites →https://doi.org/10.2139/ssrn.458620openalex-snapshot
Patents, Essential Medicines, and the Innovation Game
inferredcites →https://doi.org/10.2147/cer.s15861openalex-snapshot
The basic regulatory considerations and prospects for conducting bioavailability/bioequivalence (BA/BE) studies – an overview
inferredcites →https://doi.org/10.4081/itjm.2014.399openalex-snapshot
Generic - equivalent drugs use in internal and general medicine patients: distrust, confusion, lack of certainties or of knowledge? Part 2. Misconceptions, doubts and critical aspects when using generic drugs in the real world
inferredcites →https://doi.org/10.4103/2224-3151.115849openalex-snapshot
Generic medicines policies in the Asia Pacific region: ways forward
inferredcites →https://doi.org/10.5639/gabij.2012.0102.020openalex-snapshot
The impact of pharmaceutical pricing and reimbursement policies on generics uptake: implementation of policy options on generics in 29 European countries─an overview

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.3596559openalex-extracted
The More Monitoring, the Better Quality? Empirical Evidence from the Generic Drug Industry
inferred← citeshttps://doi.org/10.1002/ana.25353openalex-snapshot
Switching the manufacturer of antiepileptic drugs is associated with higher risk of seizures: A nationwide study of prescription data in Germany
inferred← citeshttps://doi.org/10.1002/epi4.12583openalex-snapshot
Barriers to generic antiseizure medication use: Results of a global survey by the International League Against Epilepsy Generic Substitution Task Force
inferred← citeshttps://doi.org/10.1002/pds.4205openalex-snapshot
Do patients trust the FDA?: a survey assessing how patients view the generic drug approval process
inferred← citeshttps://doi.org/10.1007/978-3-030-52848-5_3openalex-snapshot
The Conceptualisation of TCMP in Law
inferred← citeshttps://doi.org/10.1007/978-3-030-52848-5_5openalex-snapshot
EU Pharmaceutical Law Relating to WTO Rules
inferred← citeshttps://doi.org/10.1007/s10961-022-09958-6openalex-snapshot
Navigating the open innovation paradox: an integrative framework for adopting open innovation in pharmaceutical R&D in developing countries
inferred← citeshttps://doi.org/10.1007/s40258-015-0156-7openalex-snapshot
Safety and Quality of Generic Drugs: A Never Ending Debate Fostered by Economic Interests?
inferred← citeshttps://doi.org/10.1007/s40258-017-0306-1openalex-snapshot
Is Compulsory Licensing Bad for Public Health? Some Critical Comments on Drug Accessibility in Developing Countries
inferred← citeshttps://doi.org/10.1007/s40264-026-01712-3openalex-snapshot
Drug Brand Switching: A Regulatory Perspective
inferred← citeshttps://doi.org/10.1007/s43441-020-00191-7openalex-snapshot
Policy of Multisource Drug Products in Latin America: Opportunities and Challenges on the Application of Bioequivalence In Vitro Assays
inferred← citeshttps://doi.org/10.1016/b978-0-443-26472-6.00149-2openalex-snapshot
Generic Drug Policies
inferred← citeshttps://doi.org/10.1016/b978-0-443-40572-3.00015-0openalex-snapshot
Precision medicine: personalizing treatments for improved outcomes
inferred← citeshttps://doi.org/10.1016/j.bbadis.2017.12.019openalex-snapshot
Inferring anatomical therapeutic chemical (ATC) class of drugs using shortest path and random walk with restart algorithms
inferred← citeshttps://doi.org/10.1016/j.heliyon.2022.e12665openalex-snapshot
Bioequivalence studies of cetirizine tablets using the urine excretion data of healthy Ghanaian male volunteers
inferred← citeshttps://doi.org/10.1016/j.hlpt.2025.101025openalex-snapshot
Dimensions and criteria of value assessment frameworks for generic drugs: A scoping review and thematic analysis
inferred← citeshttps://doi.org/10.1016/j.jbusres.2021.08.074openalex-snapshot
Impact of stronger intellectual property rights regime on innovation: Evidence from de alio versus de novo Indian bio-pharmaceutical firms
inferred← citeshttps://doi.org/10.1016/j.vhri.2017.02.001openalex-snapshot
Applying Multi-Criteria Decision Analysis (MCDA) Simple Scoring as an Evidence-based HTA Methodology for Evaluating Off-Patent Pharmaceuticals (OPPs) in Emerging Markets
inferred← citeshttps://doi.org/10.1016/j.vhri.2018.01.003openalex-snapshot
An Evidence Framework for Off-Patent Pharmaceutical Review for Health Technology Assessment in Emerging Markets
inferred← citeshttps://doi.org/10.1016/j.yebeh.2020.107705openalex-snapshot
Manufacturer switch of anti-seizure drugs may not increase the risk of seizure recurrence in Children: A nationwide study of prescription data in Germany
inferred← citeshttps://doi.org/10.1016/s1470-2045(16)30384-9openalex-snapshot
Generic oncology drugs: are they all safe?
inferred← citeshttps://doi.org/10.1080/14737167.2018.1508345openalex-snapshot
Guidance toward the implementation of multicriteria decision analysis framework in developing countries
inferred← citeshttps://doi.org/10.1093/acprof:oso/9780199392285.003.0011openalex-snapshot
Understanding and Organizing Health Care Systems
inferred← citeshttps://doi.org/10.1093/eurpub/ckaf235openalex-snapshot
Regulations for international non-proprietary name prescribing and substitution, relevant for cross-border ePrescribing and eDispensation services in the European Union
inferred← citeshttps://doi.org/10.1108/ijopm-09-2022-0581openalex-snapshot
On the drivers of drug shortages: empirical evidence from Germany
inferred← citeshttps://doi.org/10.1108/ijphm-10-2020-0090openalex-snapshot
Branded vs. Generic drugs: the role of self-perceived seriousness of disease
inferred← citeshttps://doi.org/10.1109/ieem45057.2020.9309793openalex-snapshot
Supply Chain Risk Assessment of Generic Medicine in Indonesia Using DEMATEL-Based ANP (DANP)
inferred← citeshttps://doi.org/10.1124/jpet.121.000994openalex-snapshot
Therapeutic Basis of Generic Substitution of Antiseizure Medications
inferred← citeshttps://doi.org/10.1136/bmjopen-2024-087801openalex-snapshot
Post-market quality assessment of antibiotics: findings from a cross-sectional study using standardised patients in Tabalong and Bekasi districts, Indonesia
inferred← citeshttps://doi.org/10.1142/9789813231221_0015openalex-snapshot
Understanding Traditional Chinese Medicine from a Legal and Semantic Perspective
inferred← citeshttps://doi.org/10.1155/2022/5249922openalex-snapshot
A Randomized, Double-Masked, Active-Controlled, Crossover Phase III Equivalence Study of Generic Dorzolamide 2% versus Innovator Trusopt® Eye Drop Solution in Subjects with Open-Angle Glaucoma or Ocular Hypertension
inferred← citeshttps://doi.org/10.1155/nuf/3821193openalex-snapshot
Nurses’ Experiences of Generic Substitution in Clinical Patient Care: A Qualitative Study
inferred← citeshttps://doi.org/10.1177/1741134319833122openalex-snapshot
Generic dRug Adoption Framework: Framework to assess perceptions and identify high-quality generic drugs in oncology
inferred← citeshttps://doi.org/10.1177/1741134319848811openalex-snapshot
Generic drugs, a need to the public: USA and India – Government plans to reduce the price of abbreviated new drug application and list of generic drugs approved in year 2018
inferred← citeshttps://doi.org/10.1177/1741134319875764openalex-snapshot
Assessment of knowledge, attitude and practice among pharmacy professionals towards generic medicines in Addis Ababa, Ethiopia
inferred← citeshttps://doi.org/10.1177/17411343241275946openalex-snapshot
Generic drug adoption framework (GRAF) adapted for Colombia: Consensus methodology
inferred← citeshttps://doi.org/10.1177/27550834231167049openalex-snapshot
Assessment of community pharmacists’ knowledge of the differences between generic drugs and biosimilars: A pilot cross-sectional study
inferred← citeshttps://doi.org/10.1186/s12913-017-2682-5openalex-snapshot
“No generics, Doctor!” The perspective of general practitioners in two French regions
inferred← citeshttps://doi.org/10.1186/s12913-022-08438-9openalex-snapshot
A nationwide survey exploring physicians’ and pharmacists’ knowledge, awareness and perceptions regarding generic medicines in China
inferred← citeshttps://doi.org/10.1186/s40545-019-0171-4openalex-snapshot
Stakeholder driven development of a multi-criteria decision analysis tool for purchasing off-patent pharmaceuticals in Kuwait
inferred← citeshttps://doi.org/10.13040/ijpsr.0975-8232.8(9).3678-85openalex-snapshot
inferred← citeshttps://doi.org/10.1371/journal.pone.0311627openalex-snapshot
Evaluation of public’s knowledge, attitude and experiences towards the generic medications in building healthcare policy
inferred← citeshttps://doi.org/10.1371/journal.pone.0319674openalex-snapshot
Comparison of generic drug prices in Korea and eight high-income countries across four therapeutic classes
inferred← citeshttps://doi.org/10.14264/uql.2020.129openalex-snapshot
Investigating Trends in the Duration of the Regulatory Approval Phase for Biosimilars in the European Union and the United States of America
inferred← citeshttps://doi.org/10.1590/1413-81232017228.05762017openalex-snapshot
Impacto de intervenções para promoção do uso de medicamentos genéricos: revisão sistemática
inferred← citeshttps://doi.org/10.17305/bjbms.2021.6910openalex-snapshot
Regulatory aspects of biological medicines in Bosnia and Herzegovina
inferred← citeshttps://doi.org/10.18203/2319-2003.ijbcp20251061openalex-snapshot
A study of awareness of generic drugs amongst residents and intern doctors in a tertiary care hospital in Surat city
inferred← citeshttps://doi.org/10.18231/2455-8559.2018.0006openalex-snapshot
Attitude towards generic drugs: A comparative study among clinicians and pharmacy professionals
inferred← citeshttps://doi.org/10.18310/2446-4813.2022v8n1p117-129openalex-snapshot
Medicamentos genéricos em Portugal: estudo de avaliação do conhecimento e da perceção dos utentes
inferred← citeshttps://doi.org/10.18310/2446-4813.2022v8n1p131-144openalex-snapshot
Utilização de medicamentos genéricos em Portugal: percepções e atitudes de doentes, médicos e farmacêuticos
inferred← citeshttps://doi.org/10.18786/2072-0505-2019-47-055openalex-snapshot
The use of subcutaneous methotrexate from various manufacturers in real clinical practice: a comparative study
inferred← citeshttps://doi.org/10.21276/aimdr.2017.3.1.pc1openalex-snapshot
Comparison of Generic and Branded Drugs on Cost Effective and Cost Benefit Analysis
inferred← citeshttps://doi.org/10.2147/dddt.s106802openalex-snapshot
Clinical implications for substandard, nonproprietary medicines in multiple sclerosis: focus on fingolimod
inferred← citeshttps://doi.org/10.2147/dddt.s328106openalex-snapshot
Simultaneous Determination of Loratadine and Its Metabolite Desloratadine in Beagle Plasma by LC-MS/MS and Application for Pharmacokinetics Study of Loratadine Tablets and Omeprazole‑Induced Drug–Drug Interaction
inferred← citeshttps://doi.org/10.2174/1871520619666190305141458openalex-snapshot
Nitrogen Mustards as Alkylating Agents: A Review on Chemistry, Mechanism of Action and Current USFDA Status of Drugs
inferred← citeshttps://doi.org/10.22159/ajpcr.2018.v12i1.30010openalex-snapshot
PHARMACODYNAMICS EFFECT OF METHYLPREDNISOLONE TABLETS ON THE SERUM CONCENTRATION OF ANNEXIN A1: IN VIVO COMPARATIVE STUDY BETWEEN GENERIC AND INNOVATOR DRUG
inferred← citeshttps://doi.org/10.22270/jddt.v12i2-s.5412openalex-snapshot
Knowledge and Perceptions of Generic Drugs: A Cross Sectional Study
inferred← citeshttps://doi.org/10.24265/horizmed.2016.v16n3.03openalex-snapshot
Estudio de la biodisponibilidad relativa de una formulación multifuente de sulfametoxazol respecto al medicamento referente
inferred← citeshttps://doi.org/10.24959/cphj.21.1548openalex-snapshot
The analysis of approaches to conducting bioequivalence studies and the policy of “transparency” of their results in Ukraine, the United States and the European Union
inferred← citeshttps://doi.org/10.31533/pubsaude6.a166openalex-snapshot
Qualidade dos medicamentos genéricos no Brasil – Revisão
inferred← citeshttps://doi.org/10.31741/ijhrmlp.v5.i1.2019.1openalex-snapshot
Generic versus branded medicines
inferred← citeshttps://doi.org/10.32383/farmpol/151705openalex-snapshot
Analysis of changes in drug reimbursement based on the example of the limit groups containing beta-2 adrenergic drugs in Poland in the years 2012-2021
inferred← citeshttps://doi.org/10.3389/fbioe.2018.00071openalex-snapshot
Off-Patent Transgenic Events: Challenges and Opportunities for New Actors and Markets in Agriculture
inferred← citeshttps://doi.org/10.3389/fphar.2019.00809openalex-snapshot
Nocebo in Biosimilars and Generics in Neurology: A Systematic Review
inferred← citeshttps://doi.org/10.3389/fpubh.2025.1629835openalex-snapshot
Medicine affordability and access in India: lessons from generic–branded price variation under the Jan Aushadhi Scheme
inferred← citeshttps://doi.org/10.3390/biomedicines14091994openalex-snapshot
Comparative Analysis of SMN2 Splicing Activity and Protein Production Following In Vitro Treatment with the Generic Risdiplam Drug Vapromin® and the Reference Drug Evrysdi®
inferred← citeshttps://doi.org/10.33974/ijrpst.v1i4.196openalex-snapshot
An overview on comparative study of registration requirements for generics in US, Canada and Europe
inferred← citeshttps://doi.org/10.36948/ijfmr.2024.v06i03.20588openalex-snapshot
Pradhan Mantri Bharatiya Jan Aushadi Pariyojana – An Evaluation of Jan Aushadhi Kendra in Mumbai Metropolitan Region
inferred← citeshttps://doi.org/10.4103/ajprhc.ajprhc_60_23openalex-snapshot
Study of Knowledge, Attitude, and Practice of Prescribing Generic Medicines by Resident Doctors at a Tertiary Care Teaching Hospital
inferred← citeshttps://doi.org/10.4103/jfmpc.jfmpc_1325_24openalex-snapshot
Determinants of the generic’s prescription among general practitioners in Casablanca, Morocco: A cross-sectional study
inferred← citeshttps://doi.org/10.4103/jfmpc.jfmpc_1694_20openalex-snapshot
Opinion of patients seeking primary care regarding prescription of generic drugs: A cross-sectional study
inferred← citeshttps://doi.org/10.4103/psychiatry.indianjpsychiatry_222_17openalex-snapshot
Prescription writing
inferred← citeshttps://doi.org/10.48175/ijarsct-17662openalex-snapshot
An Empirical Study on Generic Medicine and Branded Medicine
inferred← citeshttps://doi.org/10.51583/ijltemas.2026.150100042openalex-snapshot
Beyond Affordability: Trust, Sustainability, and the Lived Experiences of Jan Aushadhi Kendra Owners
inferred← citeshttps://doi.org/10.5339/avi.2024.10openalex-snapshot
The generic drug quandary in the Mauritian context: To use or not to use?
inferred← citeshttps://doi.org/10.5530/ijopp.11.2.19openalex-snapshot
Patient Perception about Generic vs. Branded Medicines Prescribed in a Tertiary Care Hospital in Northern India -A Descriptive Study
inferred← citeshttps://doi.org/10.56831/psmph-03-091openalex-snapshot
A Quality Assessment of Generic Drugs: A Review
inferred← citeshttps://doi.org/10.5772/intechopen.85587openalex-snapshot
Perceptions and Challenges for Adoption of Generics and Biosimilars in Oncology
inferred← citeshttps://doi.org/10.58902/tcnckhpt.v3i2.141openalex-snapshot
KIẾN THỨC VÀ NHẬN THỨC CỦA SINH VIÊN DƯỢC NĂM CUỐI TẠI TRƯỜNG ĐẠI HỌC THÀNH ĐÔ VỀ THUỐC GENERIC
inferred← citeshttps://doi.org/10.59049/2790-0231.1168openalex-snapshot
Knowledge, attitude, perception, and practices of generic substitution of community pharmacists in the north al -Batinah governorate of Oman: a pilot study
inferred← citeshttps://doi.org/10.6084/m9.figshare.20522643openalex-snapshot
Additional file 1 of A nationwide survey exploring physicians’ and pharmacists’ knowledge, awareness and perceptions regarding generic medicines in China
inferred← citeshttps://doi.org/10.6084/m9.figshare.20522646openalex-snapshot
Additional file 2 of A nationwide survey exploring physicians’ and pharmacists’ knowledge, awareness and perceptions regarding generic medicines in China
inferred← citeshttps://doi.org/10.6084/m9.figshare.20522649openalex-snapshot
Additional file 3 of A nationwide survey exploring physicians’ and pharmacists’ knowledge, awareness and perceptions regarding generic medicines in China
inferred← citeshttps://doi.org/10.9734/jpri/2022/v34i44b36344openalex-snapshot
Ceftriaxone Injectables: An In vitro Evaluation of Antimicrobial Activity and Comparative Efficacy
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.